Murine models of Candida gastrointestinal colonization and dissemination

Eukaryotic Cell

Volumn 12, Issue 11, 2013, Pages 1416-1422

  Koh, Andrew Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANIMAL; CANDIDA; CANDIDIASIS; DISEASE MODEL; DISEASE TRANSMISSION; GENETICS; HUMAN; INTESTINE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; REVIEW;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DISEASE MODELS, ANIMAL; HUMANS; INTESTINES; MICE;

EID: 84886407969     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00196-13     Document Type: Review

References (99)

1. Mostov K, Su T, ter Beest M. 2003. Polarized epithelial membrane traffic: conservation and plasticity. Nat. Cell Biol. 5:287-293.
2. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-1920.
3. Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9:313-323.
4. Pizzo PA, Poplack D. 2011. Principles and practice of pediatric oncology, 6th ed, p 1531. Lippincott Williams & Wilkins, Philadelphia, PA.
5. Nucci M, Anaissie E. 2001. Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis. 33:1959-1967.
6. Miranda LN, van der Heijden IM, Costa SF, Sousa AP, Sienra RA, Gobara S, Santos CR, Lobo RD, Pessoa VP, Jr, Levin AS. 2009. Candida colonisation as a source for candidaemia. J. Hosp. Infect. 72:9-16.
7. Berg RD. 1999. Bacterial translocation from the gastrointestinal tract. Adv. Exp. Med. Biol. 473:11-30.
8. Shoham S, Levitz SM. 2005. The immune response to fungal infections. Br. J. Haematol. 129:569-582.
9. Rosen GP, Nielsen K, Glenn S, Abelson J, Deville J, Moore TB. 2005. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J. Pediatr. Hematol. Oncol. 27:135-140.
10. Pasqualotto AC, Nedel WL, Machado TS, Severo LC. 2006. Risk factors and outcome for nosocomial breakthrough candidaemia. J. Infect. 52: 216-222.
11. Marchesi JR. 2010. Prokaryotic and eukaryotic diversity of the human gut. Adv. Appl. Microbiol. 72:43-62.
12. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM. 2010. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 6:e1000713. doi:10.1371/journal.ppat.1000713.
13. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, Rotter JI, Wang HL, McGovern DP, Brown GD, Underhill DM. 2012. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314-1317.
14. Schulze J, Sonnenborn U. 2009. Yeasts in the gut: from commensals to infectious agents. Dtsch. Arztebl. Int. 106:837-842.
15. Ott SJ, Kuhbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S. 2008. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand. J. Gastroenterol. 43:831-841.
16. Hamad I, Sokhna C, Raoult D, Bittar F. 2012. Molecular detection of eukaryotes in a single human stool sample from Senegal. PLoS One 7:e40888. doi:10.1371/journal.pone.0040888.
17. Hube B. 2004. From commensal to pathogen: stage-and tissue-specific gene expression of Candida albicans. Curr. Opin. Microbiol. 7:336-341.
18. Savage DC, Dubos RJ. 1967. Localization of indigenous yeast in the murine stomach. J. Bacteriol. 94:1811-1816.
19. Rehli M. 2002. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 23:375-378.
20. Jiang X, Shen C, Yu H, Karunakaran KP, Brunham RC. 2010. Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection. Immunology 129:556-566.
21. Gibbons DL, Spencer J. 2011. Mouse and human intestinal immunity: same ballpark, different players; different rules, same score. Mucosal Immunol. 4:148-157.
22. Koh AY, Kohler JR, Coggshall KT, Van Rooijen N, Pier GB. 2008. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 4:e35. doi:10.1371/journal.ppat.0040035.
23. Pope LM, Cole GT, Guentzel MN, Berry LJ. 1979. Systemic and gastro-intestinal candidiasis of infant mice after intragastric challenge. Infect. Immun. 25:702-707.
24. Field LH, Pope LM, Cole GT, Guentzel MN, Berry LJ. 1981. Persistence and spread of Candida albicans after intragastric inoculation of infant mice. Infect. Immun. 31:783-791.
25. Kennedy MJ, Volz PA. 1985. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 23:265-273.
26. Samonis G, Anaissie EJ, Rosenbaum B, Bodey GP. 1990. A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice. Infect. Immun. 58:1514-1517.
27. Wiesner SM, Jechorek RP, Garni RM, Bendel CM, Wells CL. 2001. Gastrointestinal colonization by Candida albicans mutant strains in anti-biotic-treated mice. Clin. Diagn. Lab. Immunol. 8:192-195.
28. White SJ, Rosenbach A, Lephart P, Nguyen D, Benjamin A, Tzipori S, Whiteway M, Mecsas J, Kumamoto CA. 2007. Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog. 3:e184. doi: 10.1371/journal.ppat.0030184.
29. Schofield DA, Westwater C, Balish E. 2005. Divergent chemokine, cytokine and beta-defensin responses to gastric candidiasis in immunocompetent C57BL/6 and BALB/c mice. J. Med. Microbiol. 54:87-92.
30. Mellado E, Cuenca-Estrella M, Regadera J, Gonzalez M, Diaz-Guerra TM, Rodriguez-Tudela JL. 2000. Sustained gastrointestinal colonization and systemic dissemination by Candida albicans, Candida tropicalis and Candida parapsilosis in adult mice. Diagn. Microbiol. Infect. Dis. 38:21-28.
31. de Repentigny L, Phaneuf M, Mathieu LG. 1992. Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice. Infect. Immun. 60: 4907-4914.
32. Takahashi K, Kita E, Konishi M, Yoshimoto E, Mikasa K, Narita N, Kimura H. 2003. Translocation model of Candida albicans in DBA-2/J mice with protein calorie malnutrition mimics hematogenous candidiasis in humans. Microb. Pathog. 35:179-187.
33. Cole GT, Lynn KT, Seshan KR, Pope LM. 1989. Gastrointestinal and systemic candidosis in immunocompromised mice. J. Med. Vet. Mycol. 27:363-380.
34. Clemons KV, Gonzalez GM, Singh G, Imai J, Espiritu M, Parmar R, Stevens DA. 2006. Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob. Agents Chemother. 50:2650-2657.
35. Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL. 1987. Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect. Immun. 55:2689-2694.
36. Koh AY, Priebe GP, Pier GB. 2005. Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia. Infect. Immun. 73:2262-2272.
37. Benjamin DK, Jr, Stoll BJ, Gantz MG, Walsh MC, Sanchez PJ, Das A, Shankaran S, Higgins RD, Auten KJ, Miller NA, Walsh TJ, Laptook AR, Carlo WA, Kennedy KA, Finer NN, Duara S, Schibler K, Chapman RL, Van Meurs KP, Frantz ID, III, Phelps DL, Poindexter BB, Bell EF, O'Shea TM, Watterberg KL, Goldberg RN, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. 2010. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 126:e865-e873.
38. Brandtzaeg P. 2010. Food allergy: separating the science from the mythology. Nat. Rev. Gastroenterol. Hepatol. 7:380-400.
39. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102:11070-11075.
40. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, Antonopoulos DA, Chang EB, Claud EC. 2009. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 3:944-954.
41. Spor A, Koren O, Ley R. 2011. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9:279-290.
42. Samonis G, Gikas A, Anaissie EJ, Vrenzos G, Maraki S, Tselentis Y, Bodey GP. 1993. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob. Agents Chemother. 37:51-53.
43. van der Waaij D. 1982. Colonization resistance of the digestive tract: clinical consequences and implications. J. Antimicrob. Chemother. 10: 263-270.
44. Vollaard EJ, Clasener HA. 1994. Colonization resistance. Antimicrob. Agents Chemother. 38:409-414.
45. Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313: 1126-1130.
46. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG. 2008. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455:804-807.
47. Wagner RD, Pierson C, Warner T, Dohnalek M, Farmer J, Roberts L, Hilty M, Balish E. 1997. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect. Immun. 65:4165-4172.
48. Renz H, Brandtzaeg P, Hornef M. 2012. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat. Rev. Immunol. 12:9-23.
49. Kai-Larsen Y, Bergsson G, Gudmundsson GH, Printz G, Jornvall H, Marchini G, Agerberth B. 2007. Antimicrobial components of the neonatal gut affected upon colonization. Pediatr. Res. 61:530-536.
50. Domer JE. 1988. Intragastric colonization of infant mice with Candida albicans induces systemic immunity demonstrable upon challenge as adults. J. Infect. Dis. 157:950-958.
51. Tsai NY, Laforce-Nesbitt SS, Tucker R, Bliss JM. 2011. A murine model for disseminated candidiasis in neonates. Pediatr. Res. 69:189-193.
52. Balish E, Warner T, Pierson CJ, Bock DM, Wagner RD. 2001. Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med. Mycol. 39:261-268.
53. Balish E, Warner TF, Nicholas PJ, Paulling EE, Westwater C, Schofield DA. 2005. Susceptibility of germfree phagocyte oxidase-and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin. Infect. Immun. 73:1313-1320.
54. Cantorna M, Mook D, Balish E. 1990. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect. Immun. 58: 3813-3815.
55. Cantorna MT, Balish E. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58:1093-1100.
56. Westwater C, Balish E, Warner TF, Nicholas PJ, Paulling EE, Schofield DA. 2007. Susceptibility of gnotobiotic transgenic mice (Tgepsilon26) with combined deficiencies in natural killer cells and T cells to wild-type and hyphal signalling-defective mutants of Candida albicans. J. Med. Microbiol. 56:1138-1144.
57. Westwater C, Schofield DA, Nicholas PJ, Paulling EE, Balish E. 2007. Candida glabrata and Candida albicans; dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis. FEMS Immunol. Med. Microbiol. 51:134-139.
58. Savage DC. 1969. Microbial interference between indigenous yeast and lactobacilli in the rodent stomach. J. Bacteriol. 98:1278-1283.
59. Noverr MC, Huffnagle GB. 2004. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. 72:6206-6210.
60. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. 2004. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72:4996-5003.
61. Wagner RD, Pierson C, Warner T, Dohnalek M, Hilty M, Balish E. 2000. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J. Food Prot. 63:638-644.
62. Zwolinska-Wcislo M, Brzozowski T, Mach T, Budak A, Trojanowska D, Konturek PC, Pajdo R, Drozdowicz D, Kwiecien S. 2006. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J. Physiol. Pharmacol. 57(Suppl 9):35-49.
63. Manzoni P, Mostert M, Leonessa ML, Priolo C, Farina D, Monetti C, Latino MA, Gomirato G. 2006. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin. Infect. Dis. 42:1735-1742.
64. Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, Korpela R. 2007. Probiotics reduce the prevalence of oral candida in the elderly-a randomized controlled trial. J. Dent. Res. 86:125-130.
65. Mason KL, Erb Downward JR, Falkowski NR, Young VB, Kao JY, Huffnagle GB. 2012. Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect. Immun. 80:150-158.
66. Mason KL, Erb Downward JR, Mason KD, Falkowski NR, Eaton KA, Kao JY, Young VB, Huffnagle GB. 2012. Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect. Immun. 80:3371-3380.
67. Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, Lee YJ, Dubin KA, Socci ND, Viale A, Perales MA, Jenq RR, van den Brink MR, Pamer EG. 2012. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55:905-914.
68. Farah CS, Elahi S, Pang G, Gotjamanos T, Seymour GJ, Clancy RL, Ashman RB. 2001. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect. Immun. 69: 6110-6118.
69. Jones-Carson J, Vazquez-Torres A, Warner T, Balish E. 2000. Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis. Infect. Immun. 68:2363-2365.
70. Cleveland WW, Fogel BJ, Brown WT, Kay HE. 1968. Foetal thymic transplant in a case of Digeorge's syndrome. Lancet ii:1211-1214.
71. McCarthy GM, Mackie ID, Koval J, Sandhu HS, Daley TD. 1991. Factors associated with increased frequency of HIV-related oral candidiasis. J. Oral Pathol. Med. 20:332-336.
72. Scully C, el-Kabir M, Samaranayake LP. 1994. Candida and oral candidosis: a review. Crit. Rev. Oral Biol. Med. 5:125-157.
73. Helstrom PB, Balish E. 1979. Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans. Infect. Immun. 23:764-774.
74. Jensen J, Warner T, Balish E. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167:912-919.
75. Boyne R, Arthur JR. 1986. The response of selenium-deficient mice to Candida albicans infection. J. Nutr. 116:816-822.
76. Mullick A, Elias M, Harakidas P, Marcil A, Whiteway M, Ge B, Hudson TJ, Caron AW, Bourget L, Picard S, Jovcevski O, Massie B, Thomas DY. 2004. Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans. Infect. Immun. 72:414-429.
77. Brown GD. 2011. Innate antifungal immunity: the key role of phagocytes. Annu. Rev. Immunol. 29:1-21.
78. Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, Kinjo T, Nakamura K, Kawakami K, Iwakura Y. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8:39-46.
79. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, Brown GD. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8:31-38.
80. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, Faro-Trindade I, Brown GD, Steele C. 2009. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 182:4938-4946.
81. Carvalho A, Giovannini G, De Luca A, D'Angelo C, Casagrande A, Iannitti RG, Ricci G, Cunha C, Romani L. 2012. Dectin-1 isoforms contribute to distinct Th1/Th17 cell activation in mucosal candidiasis. Cell. Mol. Immunol. 9:276-286.
82. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5:487-497.
83. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C, Jacobs L, Jansen T, Verheijen K, Masthoff L, Morre SA, Vriend G, Williams DL, Perfect JR, Joosten LA, Wijmenga C, van der Meer JW, Adema GJ, Kullberg BJ, Brown GD, Netea MG. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361:1760-1767.
84. Gales A, Conduche A, Bernad J, Lefevre L, Olagnier D, Beraud M, Martin-Blondel G, Linas MD, Auwerx J, Coste A, Pipy B. 2010. PPAR-gamma controls dectin-1 expression required for host antifungal defense against Candida albicans. PLoS Pathog. 6:e1000714. doi:10.1371/journal.ppat.1000714.
85. Vautier S, Drummond RA, Redelinghuys P, Murray GI, MacCallum DM, Brown GD. 2012. Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect. Immun. 80: 4216-4222.
86. Denning TL, Norris BA, Medina-Contreras O, Manicassamy S, Geem D, Madan R, Karp CL, Pulendran B. 2011. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J. Immunol. 187:733-747.
87. Friswell MK, Gika H, Stratford IJ, Theodoridis G, Telfer B, Wilson ID, McBain AJ. 2010. Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice. PLoS One 5:e8584. doi:10.1371/journal.pone.0008584.
88. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-498.
89. Huang W, Na L, Fidel PL, Schwarzenberger P. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
90. De Luca A, Zelante T, D'Angelo C, Zagarella S, Fallarino F, Spreca A, Iannitti RG, Bonifazi P, Renauld JC, Bistoni F, Puccetti P, Romani L. 2010. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 3:361-373.
91. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206:299-311.
92. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, Belladonna ML, Vacca C, Conte C, Mosci P, Bistoni F, Puccetti P, Kastelein RA, Kopf M, Romani L. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37:2695-2706.
93. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-289.
94. Del Sero G, Mencacci A, Cenci E, d'Ostiani CF, Montagnoli C, Bacci A, Mosci P, Kopf M, Romani L. 1999. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect. 1:1169-1180.
95. Jawhara S, Thuru X, Standaert-Vitse A, Jouault T, Mordon S, Sendid B, Desreumaux P, Poulain D. 2008. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J. Infect. Dis. 197:972-980.
96. Rosenbach A, Dignard D, Pierce JV, Whiteway M, Kumamoto CA. 2010. Adaptations of Candida albicans for growth in the mammalian intestinal tract. Eukaryot. Cell 9:1075-1086.
97. Rahman D, Mistry M, Thavaraj S, Challacombe SJ, Naglik JR. 2007. Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes Infect. 9:615-622.
98. Taylor BN, Fichtenbaum C, Saavedra M, Slavinsky IJ, Swoboda R, Wozniak K, Arribas A, Powderly W, Fidel PL, Jr. 2000. In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. J. Infect. Dis. 182:955-959.
99. Naglik JR, Fidel PL, Jr, Odds FC. 2008. Animal models of mucosal Candida infection. FEMS Microbiol. Lett. 283:129-139.